Dumont & Blake Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,802
| Closed | -$1.04M | – | 214 |
|
|
2025
Q4 | $1.04M | Sell |
10,802
-154
| -1% | -$15K | 0.25% | 94 |
|
|
2025
Q3 | $1.04M | Sell |
10,956
-37
| -0.3% | -$3.4K | 0.25% | 91 |
|
|
2025
Q2 | $958K | Buy |
10,993
+58
| +0.5% | +$4.92K | 0.25% | 96 |
|
|
2025
Q1 | $983K | Buy |
10,935
+95
| +0.9% | +$8.5K | 0.28% | 89 |
|
|
2024
Q4 | $866K | Buy |
10,840
+25
| +0.2% | +$2.16K | 0.23% | 101 |
|
|
2024
Q3 | $974K | Sell |
10,815
-10,991
| -50% | -$925K | 0.26% | 93 |
|
|
2024
Q2 | $1.72M | Buy |
21,806
+10,788
| +98% | +$884K | 0.24% | 99 |
|
|
2024
Q1 | $960K | Sell |
11,018
-377
| -3% | -$32.2K | 0.28% | 93 |
|
|
2023
Q4 | $939K | Sell |
11,395
-795
| -7% | -$60.6K | 0.29% | 90 |
|
|
2023
Q3 | $955K | Buy |
12,190
+60
| +0.5% | +$5.02K | 0.32% | 81 |
|
|
2023
Q2 | $1.07M | Sell |
12,130
-582
| -5% | -$50.1K | 0.35% | 78 |
|
|
2023
Q1 | $1.02M | Buy |
12,712
+186
| +1% | +$15.2K | 0.35% | 79 |
|
|
2022
Q4 | $974K | Sell |
12,526
-666
| -5% | -$54K | 0.34% | 79 |
|
|
2022
Q3 | $1.06M | Buy |
13,192
+1,549
| +13% | +$139K | 0.4% | 73 |
|
|
2022
Q2 | $1.04M | Buy |
11,643
+52
| +0.4% | +$5.27K | 0.34% | 80 |
|
|
2022
Q1 | $1.29M | Buy |
11,591
+57
| +0.5% | +$6.02K | 0.35% | 78 |
|
|
2021
Q4 | $1.19M | Buy |
11,534
+337
| +3% | +$39K | 0.31% | 90 |
|
|
2021
Q3 | $1.4M | Buy |
11,197
+5
| +0% | +$647 | 0.4% | 71 |
|
|
2021
Q2 | $1.39M | Buy |
11,192
+5
| +0% | +$628 | 0.4% | 75 |
|
|
2021
Q1 | $1.32M | Buy |
11,187
+165
| +1% | +$19.3K | 0.41% | 74 |
|
|
2020
Q4 | $1.29M | Sell |
11,022
-265
| -2% | -$29.2K | 0.44% | 65 |
|
|
2020
Q3 | $1.17M | Buy |
11,287
+271
| +2% | +$27.2K | 0.45% | 67 |
|
|
2020
Q2 | $1.01M | Sell |
11,016
-224
| -2% | -$21.5K | 0.42% | 70 |
|
|
2020
Q1 | $1.01M | Buy |
11,240
+131
| +1% | +$13.9K | 0.52% | 57 |
|
|
2019
Q4 | $1.26M | Buy |
11,109
+15
| +0.1% | +$1.65K | 0.5% | 56 |
|
|
2019
Q3 | $1.21M | Sell |
11,094
-1,640
| -13% | -$171K | 0.51% | 56 |
|
|
2019
Q2 | $1.24M | Sell |
12,734
-50
| -0.4% | -$4.57K | 0.52% | 54 |
|
|
2019
Q1 | $1.16M | Sell |
12,784
-50
| -0.4% | -$4.47K | 0.49% | 60 |
|
|
2018
Q4 | $1.17M | Sell |
12,834
-35
| -0.3% | -$3.27K | 0.55% | 53 |
|
|
2018
Q3 | $1.27M | Buy |
12,869
+350
| +3% | +$32.4K | 0.49% | 61 |
|
|
2018
Q2 | $1.07M | Buy |
12,519
+193
| +2% | +$16.1K | 0.45% | 74 |
|
|
2018
Q1 | $989K | Sell |
12,326
-15
| -0.1% | -$1.24K | 0.42% | 83 |
|
|
2017
Q4 | $997K | Sell |
12,341
-207
| -2% | -$16.6K | 0.4% | 88 |
|
|
2017
Q3 | $976K | Sell |
12,548
-95
| -0.8% | -$7.89K | 0.42% | 88 |
|
|
2017
Q2 | $1.12M | Sell |
12,643
-130
| -1% | -$11K | 0.5% | 74 |
|
|
2017
Q1 | $1.03M | Buy |
12,773
+19
| +0.1% | +$1.48K | 0.46% | 77 |
|
|
2016
Q4 | $908K | Buy |
12,754
+30
| +0.2% | +$2.36K | 0.43% | 84 |
|
|
2016
Q3 | $1.1M | Hold |
12,724
| – | – | 0.54% | 60 |
|
|
2016
Q2 | $1.1M | Sell |
12,724
-340
| -3% | -$27.5K | 0.55% | 58 |
|
|
2016
Q1 | $980K | Sell |
13,064
-207
| -2% | -$15.6K | 0.51% | 72 |
|
|
2015
Q4 | $1.02M | Sell |
13,271
-6,950
| -34% | -$523K | 0.52% | 71 |
|
|
2015
Q3 | $1.35M | Buy |
20,221
+198
| +1% | +$14.6K | 0.73% | 45 |
|
|
2015
Q2 | $1.48M | Sell |
20,023
-50
| -0.2% | -$3.82K | 0.73% | 46 |
|
|
2015
Q1 | $1.56M | Sell |
20,073
-400
| -2% | -$30.3K | 0.76% | 48 |
|
|
2014
Q4 | $1.48M | Sell |
20,473
-190
| -0.9% | -$13.2K | 0.73% | 49 |
|
|
2014
Q3 | $1.28M | Sell |
20,663
-7,410
| -26% | -$471K | 0.66% | 53 |
|
|
2014
Q2 | $1.79M | Sell |
28,073
-905
| -3% | -$55K | 0.9% | 33 |
|
|
2014
Q1 | $1.78M | Sell |
28,978
-963
| -3% | -$56.1K | 0.93% | 32 |
|
|
2013
Q4 | $1.72M | Sell |
29,941
-3,908
| -12% | -$222K | 0.89% | 35 |
|
|
2013
Q3 | $1.8M | Hold |
33,849
| – | – | 0.86% | 34 |
|
|
2013
Q2 | $1.74M | Buy |
+33,849
| New | +$1.67M | 1.05% | 29 |
|
Other funds holding MDT
Dumont & Blake Investment Advisors's MDT Position: Q1 2026 in Review
Dumont & Blake Investment Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 10,802 shares — an estimated $1.04M sold.
Dumont & Blake Investment Advisors first reported a position in MDT in Q2 2013 and held it in 51 quarters. The position peaked at $1.8M in Q3 2013. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Dumont & Blake Investment Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Dumont & Blake Investment Advisors sold 10,802 Medtronic shares in Q1 2026, an estimated $1.04M.
- Dumont & Blake Investment Advisors first reported a position in Medtronic in Q2 2013 and held it in 51 quarters.
- Dumont & Blake Investment Advisors's Medtronic position peaked at $1.8M in Q3 2013.
- 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.